More women will survive breast cancer with Arimidex (anastrozole) than tamoxifen
12th Dec 2005, 09:24 GMT
New data show that Arimidex (anastrozole) is the first and only breast cancer drug in the aromatase inhibitor class that provides postmenopausal women with early breast cancer, a significantly better chance of surviving their disease, compared with those women who remain on tamoxifen.
More women will survive breast cancer with Arimidex (anastrozole) than tamoxifen related news:
- Survival Benefit For Arimidex™ In Early Breast Cancer — Medical News Today RSS/XML Feed
- Breast cancer drug may work in lung cancer — United Press International - Health Business
- Gene variation affects tamoxifen's benefit for breast cancer — EurekAlert! - Cancer
- Mayo Clinic reports tamoxifen benefit for breast-cancer patients tied to inherited gene — EurekAlert! - Cancer
- San Antonio Breast Cancer Symposium Research Shows Hormone Replacement Therapy is No Help for Women Taking Tamoxifen — Mammography News from StratCenter.com
- Switching to Anastrozole After Tamoxifen May Improve Overall Survival in Breast Cancer — Medscape Pharmacist Headlines
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Long-term benefits for women with breast cancer who take letrozole — OnMedica Latest News
- New Clinical Data Show Dramatic Benefits of Femara for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment — Mammography News from StratCenter.com
- Gene change inhibits tamoxifen -- study — United Press International - Health Business
Latest news from OnMedica Latest News:
- Diagnosis by internet now popular and can work
- Draft NICE guidance on substance misuse available for consultation
- MDU advise on healthcare assitants giving flu vaccinations
- Drinking not recognised as mouth cancer cause
- More confusion over painkillers revealed
- New sexual health campaign for young adults
- NHS financial crisis is squeezing medical education
- World Diabetes Day is today
- NHS patients to choose hospitals through local libraries
- Patient hospital choice system needs improvement